ROCHE HOLDING AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 245.6 EUR | -0.14% |
|
-.--% | -.--% |
| 09:58am | Roche: approval in lung cancer in the United States | CF |
| 08:48am | Nykode Therapeutics Launches Phase 2 Clinical Trial for Cervical Cancer Vaccine | MT |
Performance
| 1 day | -0.14% | ||
| 5 years | +5.70% | ||
| 10 years | +16.90% |
Volumes
marketsDaily volume
737
Estimated daily volume
4 410
Record volume 1
28 964
Record volume 2
28 118
Record volume 3
27 308
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
176 567 379 664
Capitalization (USD)
194 435 998 486
Net sales (CHF)
58 716 000 000
Net sales (USD)
64 658 059 200
Number of employees
103 605
Sales / Employee (CHF)
566 729
Sales / Employee (USD)
624 082
Free-Float
88.91 %
Free-Float capitalization (EUR)
159 358 283 008
Free-Float capitalization (USD)
175 485 341 249
Highs and lows
5 years
226.40
253.80
10 years
178.38274.75
Indicators
Moving average 5 days
247.46
Moving average 100 days
239.77
Price spread / (MMA5)
+0.76%
Price spread / (MMA100)
-2.37%
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.14% | -.--% | -.--% | -.--% | 194B | ||
| -0.64% | -1.80% | +27.97% | +101.66% | 672B | ||
| -0.05% | -1.97% | +23.58% | +53.75% | 550B | ||
| +0.67% | -2.05% | -7.02% | -9.48% | 351B | ||
| -0.13% | -0.75% | +14.85% | +9.04% | 317B | ||
| +0.25% | -1.71% | +6.25% | +3.18% | 292B | ||
| -0.92% | -1.88% | +2.42% | -9.47% | 211B | ||
| -0.33% | -2.09% | -0.67% | -4.47% | 203B | ||
| -0.12% | -3.61% | -11.81% | -37.39% | 144B | ||
| -0.53% | -2.71% | -8.80% | +6.74% | 141B | ||
| +0.77% | -0.66% | -4.30% | -15.75% | 113B | ||
| +0.96% | -1.67% | -5.87% | -31.23% | 97.89B | ||
| -1.15% | -3.63% | -18.33% | -21.03% | 82.5B | ||
| -0.33% | -3.89% | +8.92% | +6.31% | 80.65B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| +2.20% | +0.09% | +19.73% | -3.60% | 56.26B | ||
| Average | +0.13% | -1.53% | +3.13% | +3.22% | ||
| Weighted average by Cap. | +0.02% | -1.51% | +9.28% | +24.17% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2019 | +14.10% | ||
| 2018 | +2.07% | ||
| 2017 | -2.47% | ||
| 2016 | -16.04% | ||
| 2015 | +15.02% | ||
| 2014 | +10.70% | ||
| 2013 | +31.80% | ||
| 2012 | +17.05% | ||
| 2011 | +18.46% | ||
| 2010 | -7.00% | ||
| 2009 | +7.97% | ||
| 2008 | -6.50% | ||
| 2007 | -13.89% | ||
| 2006 | +8.33% | ||
| 2005 | +48.66% | ||
| 2004 | +5.59% | ||
| 2003 | +18.56% |
- Stock Market
- Equities
- ROG Stock
- RHO5 Stock
- Quotes Roche Holding AG
